2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052-2081. doi:10.1111/ jgs.18372
2.
American Diabetes Association Professional Practice Committee. American Diabetes Association. 6. Glycemic goals and hypoglycemia: Standards of Care in Diabetes — 2024. Diabetes Care. 2024[a];47(Suppl 1):S111-S125. doi:10.2337/dc24-S006
3.
American Diabetes Association Professional Practice Committee. American Diabetes Association. 13. Older adults: Standards of Care in Diabetes — 2024. Diabetes Care. 2024[b];47(Suppl 1):S244-S257. doi:10.2337/dc24-S013
4.
Association of Diabetes Care and Education Specialists. Insulin cost-savings resource guide. Updated September8, 2023[a]. Accessed March 16, 2024. https://www.adces.org/docs/default-source/handouts/costsavingsresources/ehandout_hcp_ costsaving_insulincostsavingresource2023.pdf?Status=Master& sfvrsn=1e56359_15
DelaraMMurrayLJafariB, et al. Prevalence and risk factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatrics. 2022;22:601. doi:10.1186/s12877-022-03279-x
8.
DuffALatchfordG.Using motivational interviewing to improve medicines adherence. Pharm J. 2016;296(7889). doi:10.1211/ PJ.2016.20200954
9.
Gorgojo-MartinezJJMezquita-RayaPCarretero-GomezJ, et al. Clinical recommendations to manage gastrointestinal adverse events in patients treated with GLP-1 receptor agonists: a mul-tidisciplinary expert consensus. J Clin Med. 2023;12(1):145. doi:10.3390/jcm12010145
KrepostmanNKramerH.Lower urinary tract symptoms should be queried when initiating sodium glucose co-transporter 2 inhibitors. Kidney360. 2021;2(4):751-754. doi:10.34067/ KID.0000472021
13.
LeRoithDBiesselsGJBraithwaiteSS, et al. Treatment of diabetes in older adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1520-1574. doi:10.1210/jc.2019-00198
14.
MorrisD.Avoiding and managing side effects of type 2 diabetes treatments. J Prescr Pract. 2023;5(4). doi:10.12968/jprp.2023.5.4.158
15.
RogerVL.Epidemiology of heart failure. Circ Res. 2021;128(10):1421-1434. doi:10.1161/ CIRCRESAHA.121.318172
WhartonSDaviesMDickerDet al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations from clinical practice. Postgrad Med J. 2022;134(1):14-19. doi:10.1080/00325481.2021.2002616
18.
WildingJFernandoKMilneN, et al. SGLT2 inhibitors in type 2 diabetes management: key evidence and implications for clinical practice. Diabetes Ther. 2018;9:1757-1773. doi:10.1007/ s13300-018-0471-8
19.
WinterJMacInnisRJWattanapenpaiboonN, et al. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr. 2014;99:875-890. doi:10.3945/ajcn.113.068122